ABSTRACT
INTRODUCTION
Although the prevalence of gestational diabetes mellitus (GDM) is approximately 7% in Australia, it accounts for almost 85% of all cases of diabetes in pregnancy 1 . There is a clear causal link between maternal hyperglycemia and poor perinatal outcome 2, 3 , with significantly increased rates of intrapartum fetal compromise, Cesarean section (CS), macrosomia, low Apgar scores, admission to the neonatal intensive care unit, surfactant use, sepsis and injury at birth in diabetic women relative to non-diabetic women 4 . Although the increased risk of adverse perinatal outcome is multifactorial in nature and, in part, attributable to the increased risk of congenital malformations and preterm birth, there is considerable evidence that macro-and microscopic aberrations in placental and cord angioarchitecture, as well as perturbations in immune and endothelial function, exist in diabetic pregnancies and also contribute to adverse outcomes in these women 5, 6 . Whilst GDM is sometimes considered to be a milder form of metabolic disturbance than pre-GDM, placental changes specific to GDM have been described. These changes reflect a hypervascularized, hyperproliferative and pro-inflammatory cellular environment 5, 7 and are believed to be secondary to maternal hyperglycemia and fetal hyperinsulinemia, with a consequent imbalance of decreased placental oxygen supply and increased fetal oxygen demand 5 . As these placental abnormalities contribute to the risk of complications, identifying pregnancies with an abnormal maternal-placental-fetal compartment that are most likely to experience adverse clinical outcomes is important.
Given the increased risk of late pregnancy complications, particularly stillbirth, some international guidelines 8 now recommend planned delivery by 39 + 0 weeks' gestation for women with pre-GDM and no later than 41 + 0 weeks for those with GDM. These guidelines also recommend assessment of fetal wellbeing late in pregnancy, although the type of monitoring is often not specified.
The cerebroplacental ratio (CPR) is the ratio of the fetal middle cerebral artery (MCA) pulsatility index (PI) to the umbilical artery (UA) PI. A low CPR is associated with a myriad of adverse obstetric and perinatal outcomes 9 and may be considered a surrogate marker of suboptimal fetal growth or placental function 10 . However, there are limited data regarding the utility of CPR in a diabetic cohort. The objective of this study was to assess the relationship between CPR and obstetric and perinatal outcomes in pregnancies complicated by GDM, grouped according to diabetes treatment/control, and to determine whether CPR measured at 34 + 0 to 36 + 6 weeks' gestation is predictive of adverse outcome. To our knowledge, there has been no study assessing specifically the value of CPR in a GDM cohort, although the study of Fadda et al. suggests that abnormal UA and MCA Doppler indices in GDM pregnancies are associated with adverse perinatal outcome 11 .
METHODS
This was a retrospective cohort study of pregnant women with GDM who delivered at the Mater Mothers' Hospital in Brisbane, Australia, between January 2007 and December 2015. The Mater Mothers' Hospital is a major tertiary center in the state of Queensland and is the largest maternity hospital in Australia, with a rate of approximately 10 000 deliveries per annum. Previous prospectively collected maternal demographic data were cross-referenced against the Institution's ultrasound and neonatal databases to correlate outcomes. The study protocol was assessed and approved by the Hospital's Human Research Ethics Committee (reference number HREC/14/MHS/37). All women with a non-anomalous singleton fetus and a diagnosis of GDM (regardless of treatment) who underwent an ultrasound scan between 34 + 0 and 36 + 6 weeks' gestation with data recorded for both MCA-PI and UA-PI (to enable calculation of CPR) were eligible for inclusion in the study. At the Mater Mothers' Hospital, all women with diabetes in pregnancy receive serial ultrasound scans to assess fetal growth and wellbeing, with the final scan before delivery generally taking place between 34 + 0 and 36 + 6 weeks' gestation. GDM was defined as a diagnosis of diabetes mellitus on the basis of an abnormal glucose tolerance test using the criteria of the Australian Diabetes in Pregnancy Society 12 . Demographic data that were collected included maternal age, parity, body mass index (BMI), ethnicity (Caucasian, Asian, Indigenous, Indian or other), smoking status, maternal disease (thyroid disease, hypertension) and mode of conception. Indigenous ethnicity refers to patients of Aboriginal or Torres Strait Islander origin. Gestational age was calculated using the last menstrual period or earliest ultrasound examination, or by a correlation with both. Doppler parameters were recorded in the absence of fetal breathing movements. An automated tracing method, incorporating at least three consecutive waveforms, was employed and repeated three times to obtain the mean PI. The angle of insonation was maintained at < 30
• . The MCA, either right or left depending on waveform quality, was imaged using color Doppler and the waveform was recorded from the proximal third of the vessel distal to its origin at the circle of Willis. UA Doppler waveforms were recorded from a free loop of the umbilical cord. CPR was calculated by dividing MCA-PI by UA-PI. Outcomes analyzed included mode of and indication for delivery, birth weight, birth-weight centile (< 10 th or > 90 th ), preterm delivery (< 37 weeks' gestation) and adverse perinatal outcome. Adverse perinatal outcome was defined as a composite measure of any of perinatal death (fetal or neonatal), admission to the neonatal critical care unit (NCCU), severe respiratory distress, 5-min Apgar score < 7, significant hypoglycemia requiring treatment, or acidosis at birth (pH ≤ 7.0 or lactate ≥ 6 mmol/L). NCCU admission included admission to the special care nursery, intensive care nursery or intensive care unit. Outcomes were stratified according to the type of treatment for GDM (diet, oral hypoglycemic agent (OHA) or insulin), as well as CPR centiles (< 10 th , th , > 90 th ). Given the retrospective nature of this study and the difficulty in applying a rigorous definition to the diagnosis of fetal compromise, we chose to adopt a pragmatic approach and used the primary indication for delivery/intervention, as recorded in the perinatal database, and cross-referenced this with the operative notes. We considered this definition reasonable as the diagnosis of fetal compromise would generally have been made on the basis of an abnormal fetal-heart pattern, fetal-scalp pH or lactate, fully accepting the limitations of this methodology in our analysis.
Statistical analysis
The Kruskal-Wallis test was used for comparison of median values between groups, for data that showed a skewed distribution, and ANOVA was used for comparison of mean values between groups, for data that were normally distributed. Proportions were compared using the chi-square test or Fisher's exact test, for expected frequencies that were below five. Statistics are reported as mean ± SD or median (interquartile range) for normally and non-normally distributed variables, respectively, or as the number of observations and the percentage of the total. Univariate analysis was performed by logistic regression, and odds ratios (ORs) with 95% CI were reported for insulin-controlled diabetes and for CPR < 10 th centile compared with the other treatment groups and with CPR ≥ 10 th centile, respectively. Data were analyzed using R Commander (R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at P < 0.05. No adjustment was made for multiple comparisons. Data are given as mean ± SD, median (interquartile range) or n (%). Data available for: *420 women, †138 women; ‡195 women. ART, assisted reproductive techniques; BMI, body mass index; CS, Cesarean section; GA, gestational age; MCA, middle cerebral artery; NRFS, non-reassuring fetal status; PI, pulsatility index; UA, umbilical artery.
RESULTS
During the study period, there were 1089 women with GDM who met the inclusion criteria. Of these, 563 (51.7%) had diet-controlled GDM, 211 (19.4%) were taking OHA and 315 (28.9%) required insulin. Table 1 shows the maternal demographics, intrapartum outcomes and ultrasound characteristics of the three treatment groups. Women who required insulin were older, had a higher BMI and were more likely to be of Caucasian or Indigenous ethnicity than women in the other two groups. In contrast, Asian women were more likely to have diet modification alone for adequate glycemic control compared with women of other ethnicities. There was no difference in parity, mode of conception, hypertension, thyroid disease or smoking rates between the groups. There was no difference in median duration of labor between groups. Furthermore, there were no significant differences between treatment groups when comparing overall rates of emergency CS, CS for non-reassuring fetal status (NRFS; intrapartum fetal compromise) or emergency CS for other indications. The rate of elective CS was, however, higher in the insulin-treated cohort.
There were no significant differences in any of the Doppler indices or the CPR between the three groups. Perinatal outcomes are detailed in Table 2 . Mean gestational age at delivery was significantly different between the three groups, with women in the diet-controlled cohort delivering later than women in the other two groups. Insulin-treated women had the highest proportion of preterm deliveries (36.8%, 116/315). There was no difference in mean birth weight or prevalence of neonates with birth weight < 10 th centile between groups. There was, however, an increased risk of delivering a neonate with birth weight > 90 th centile in the insulin-treated group compared with the other groups (OR, 1.55 (95% CI, 1.03-2.34); P = 0.036). Neonatal outcomes were poorer in the insulin-treated cohort, with higher rates of NCCU admission, respiratory distress, hypoglycemia and perinatal death. The insulin-treated group also had a significantly increased risk of having adverse composite neonatal outcome (OR, 1.75 (95% CI, 1.34-2.28); P < 0.001). Table 3 details the intrapartum and perinatal outcomes according to CPR centile categories. There was no difference in mode of delivery between CPR groups. Although the cohort with CPR < 10 th centile had the highest rate of emergency CS for NRFS, this did not reach statistical significance. Mean gestational age at delivery was lowest in those with CPR < 10 th centile and highest in those with CPR > 90 th centile (37.2 weeks vs 38.2 weeks, P < 0.001). Fetuses with CPR < 10 th centile had a 3.32-fold (95% CI, 2.22-4.99; P < 0.001) increased risk of being delivered preterm (< 37 weeks). Mean birth weight was significantly lower in fetuses with CPR < 10 th centile compared with those with CPR > 90 th centile (2734 g vs 3508 g, P < 0.001). CPR < 10 th centile conferred an eight-fold (OR = 8.22 (95% CI, 5.19-13.02); P < 0.001) increase in the risk of delivering a neonate with birth weight < 10 th centile. CPR < 10 th centile was associated with a 2.93-fold (95% CI, 1.95-4.40; P < 0.001) increased risk of adverse composite neonatal outcome. Table 4 shows intrapartum and perinatal outcomes stratified according to CPR centile and subgrouped according to diabetes treatment. There was no significant difference in birth weight between treatment groups within each CPR category. There was, however, a significant difference in gestational age at delivery, with a significantly lower gestational age in those treated with insulin in the groups with CPR 10-90 th centile and > 90 th centile (both P < 0.001). There was no difference in composite adverse outcome between treatment groups among those with CPR < 10 th centile and > 90 th centile; however, there were significantly different rates of composite adverse outcome between the three treatment groups in those with CPR 10-90 th centile (P < 0.001). Several differences in mode of delivery were observed between treatment groups within the cohorts with CPR 10-90 th centile and < 10 th centile. Significantly different rates of elective CS were observed in those with CPR < 10 th centile, with a trend toward a higher rate in the insulin-treated group. Likewise, in the 10-90 th centile group, there were significantly different rates of spontaneous vaginal delivery (SVD), overall CS and elective CS, with the highest rate of SVD seen in the diet-controlled group and higher rates of overall CS and elective CS in the insulin-treated group. Table 5 shows intrapartum and perinatal outcomes stratified according to diabetes treatment and subgrouped according to CPR centile. There was no difference in mode of delivery between CPR centile groups in any of the treatment cohorts, except for a higher rate of emergency CS for NRFS in women requiring OHA with CPR < 10 th centile. Mean gestational age at delivery and birth weight were significantly different between CPR centile groups for all GDM treatment groups; in each treatment group, those with CPR < 10 th centile had earlier delivery and lower birth weight, and gestational age at delivery and birth weight increased with increasing CPR. Across all treatment groups, there was a significant difference in the proportion of cases with composite adverse outcomes between CPR centiles, with highest rates consistently seen in cases with CPR < 10 th centile compared with any other centile group (OR, 3.1 (95% CI, 1.76-5.30), P < 0.001 for diet-controlled GDM; 3.3 (95% CI, 1.23-8.98), P = 0.018 for OHA-treated GDM; and 2.7 (95% CI, 1.23-5.96), P = 0.013 for insulin-controlled GDM).
DISCUSSION
The results from this large study demonstrate an association between low CPR (< 10 th centile) between 34 + 0 and 36 + 6 weeks' gestation in GDM pregnancies and lower birth weight, higher prevalence of birth weight < 10 th centile and worse perinatal outcomes, regardless of the type of treatment for GDM. Low CPR was associated with a high rate of emergency CS for NRFS in OHA-treated pregnancies. Our results suggest that low CPR increases the risk of delivery < 37 weeks in all GDM treatment groups, with the highest risk seen in those requiring OHA.
There are now good data, from both prospective 13,14 and retrospective studies 15, 16 , linking low CPR with suboptimal fetal growth at term, increased rates of intrapartum compromise and emergency CS, poor condition at birth and increased admission to NCCU. In addition, low CPR may reflect failure of the fetus to reach its genetic growth potential at term 10, 17 , despite normal birth weight. Fetuses with reduced fetoplacental reserves prior to labor have a decreased ability to tolerate the progressive hypoxic stress caused by intrapartum uterine contractions which reduce uterine blood flow by up to 60% 18 . Low CPR reflects suboptimal placental function and subsequent fetal cardiovascular compensation and thus appears to be a better predictor of outcome than is UA-PI or MCA-PI individually 9 . Hence, it is probably a good modality for assessment of fetal wellbeing, given the specific placental abnormalities seen in diabetic pregnancies.
The increasing global prevalence of GDM and associated complications is a challenge for obstetric healthcare providers. There is good evidence that strict glycemic control 19 combined with planned delivery reduces both obstetric and perinatal complications. Improved perinatal mortality rates are partly attributable to enhanced prenatal care, including implementing rigorous blood glucose monitoring, antenatal fetal-wellbeing assessment protocols and timely delivery. Nevertheless, stillbirth of non-anomalous fetuses in diabetic pregnancies is unpredictable and not consistently correlated to the degree of maternal hyperglycemia, suggesting a multifactorial etiology. This complexity in causation presents challenges in determining the most appropriate method of antenatal monitoring. Currently, there is no single preferred method of fetal surveillance in diabetic pregnancies. Evidence regarding the use of fetoplacental Doppler in monitoring GDM pregnancies is conflicting, with several small, retrospective studies reporting no significant difference in UA-PI of GDM patients compared with that of non-diabetic controls 20, 21 . In addition, there are data suggesting that fetal MCA-PI in GDM pregnancies is higher than in non-diabetic pregnancies 22 . Despite this uncertainty, abnormal fetal Doppler has been associated with increased incidence of perinatal complications, including CS for fetal compromise 11 . Indeed, a recent review proposed CPR evaluation in specific clinical conditions to assess its utility in predicting adverse outcome 9 . Given that a GDM diagnosis may include women with unrecognized diabetes predating the pregnancy and those who develop insulin resistance late in pregnancy, any placental compromise is likely to be variable depending on when metabolic dysregulation begins. In our view, given such variation in placental abnormalities and associated risk of fetal growth perturbations, CPR would be a particularly useful adjunct in assessing fetal wellbeing in a diabetic cohort, as in the general population.
Although there was higher prevalence of emergency CS for NRFS in those with CPR < 10 th centile compared with those with CPR of th and > 90 th centiles (OR, 1.50 (95% CI, 0.62-3.64), P = 0.369), consistent with data from unselected populations 13, 16 , this difference was not statistically significant. One explanation may be the confounding effect of gestational age, as almost all women with GDM were induced. Indeed, the mean gestational age at delivery in the diet-, OHA-and insulin-controlled groups was < 39 weeks (38.2, 38.0 and 37.6 weeks, respectively). This slightly earlier delivery may explain why, even in the group with CPR < 10 th centile, intrapartum fetal compromise was observed less frequently than in previous studies 13, 16 in which the gestational age at delivery was later.
The mean Doppler indices in our three treatment groups correlated with those reported previously 15, [20] [21] [22] , supporting the observation of comparable CPR between GDM and non-GDM patients. We found the highest mean CPRs in the insulin-treated group, an observation noted by other investigators 23 . Our results are also in agreement with those of Fadda et al., showing that abnormal UA and MCA Doppler indices and low CPR in GDM pregnancies are associated with adverse perinatal outcome 11 . In our study, within each treatment group, women with CPR < 10 th centile had the lowest birth weight and gestational age at delivery and higher rates of composite adverse neonatal outcome.
The strengths of our study include the large number of cases from a tertiary center and the inclusion of clinically relevant outcomes. The study limitations are intrinsic to the retrospective nature of the study. The long study period of 9 years meant that we encountered evolution in hospital policy and practice, importantly including a change in the diagnostic criteria for GDM, which potentially affected the relationship between diabetes status, Doppler indices and outcomes. In addition, interand intrasonographer variability was unknown and not all outcomes of interest were necessarily recorded reliably. We were unable to confirm treatment adequacy and glycemic control, gestational age at GDM diagnosis or duration of treatment, all potential confounding factors. Whilst it is possible that estimated fetal weight may have been considered when deciding mode of delivery, the CPR itself was unlikely to influence such decisions as this parameter was not included in the ultrasound report. Furthermore, all cases had positive end-diastolic flow in the UA and thus would not have been considered as abnormal by the treating obstetrician.
Despite these limitations, we have demonstrated that low CPR in a GDM cohort is associated with low birth weight, preterm birth and increased risk of adverse perinatal outcome. We have also shown no difference in mean CPR between GDM treatment groups. To our knowledge, this is the first study assessing the utility of CPR, stratified according to type of GDM treatment, for the prediction of intrapartum and perinatal outcomes. Our findings add to the increasing data on the utility of CPR in risk stratification of late-gestation pregnancies and may assist in clinical management. Further prospective studies are clearly necessary to establish the role of CPR in specific medical conditions, including diabetes.
